PPADS and suramin as antagonists at cloned P2Y‐ and P2U‐purinoceptors
Open Access
- 1 June 1996
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 118 (3) , 704-710
- https://doi.org/10.1111/j.1476-5381.1996.tb15457.x
Abstract
The effect of suramin and pyridoxalphosphate‐6‐azophenyl‐2′,4′‐disulphonic acid (PPADS) on the stimulation of phospholipase C in 1321N1 cells transfected with the human P2U‐purinoceptor (h‐P2U‐1321N1 cells) or with the turkey P2Y‐purinoceptor (t‐P2Y‐1321N1 cells) was investigated. 2‐Methylthioadenosine triphosphate (2MeSATP) was used as the agonist at t‐P2Y‐1321N1 cells and uridine triphosphate (UTP) at h‐P2U‐1321N1 cells. Suramin caused a parallel shift to the right of the concentration‐response curves for 2MeSATP in the t‐P2Y‐1321N1 cells, yielding a Schild plot with a slope of 1.16 ± 0.08 and a pA2 value of 5.77 ± 0.11. Suramin also caused a shift to the right of concentration‐response curves for UTP in the h‐P2U‐1321N1 cells, and on Schild plots gave a slope different from unity (1.57 ± 0.19) and an apparent pA2 value of 4.32 ± 0.13. Suramin was therefore a less potent antagonist at the P2U‐purinoceptor than the P2Y‐purinoceptor. In the presence of the ectonucleotidase inhibitor, ARL 67156 (6‐N,N‐diethyl‐β,γ‐dibromomethylene‐D‐ATP) there was no significant difference in the EC50 or shapes of curves with either cell type, and no difference in pA2 values for suramin. PPADS caused an increase in the EC50 for 2MeSATP in the t‐P2Y‐1321N1 cells. The Schild plot had a slope different from unity (0.55 ± 0.15) and an X‐intercept corresponding to an apparent pA2 of 5.98 ± 0.65. PPADS up to 30 μm had no effect on the concentration‐response curve for UTP with the h‐P2U‐1321N1 cells. In conclusion, suramin and PPADS show clear differences in their action at the 2 receptor types, in each case being substantially more effective as an antagonist at the P2Y‐purinoceptor than at the P2U‐purinoceptor. Ectonucleotidase breakdown had little influence on the nature of the responses at the two receptor types, or in their differential sensitivity to suramin.Keywords
This publication has 38 references indexed in Scilit:
- Is there a basis for distinguishing two types of P2-purinoceptor?Published by Elsevier ,2002
- Cloning, Expression, and Chromosomal Localization of the Human Uridine Nucleotide Receptor GenePublished by Elsevier ,1995
- Cloning and Functional Expression of a Human Uridine Nucleotide ReceptorJournal of Biological Chemistry, 1995
- Cloning and Characterization of a Bovine P2Y Receptor ∮Biochemical and Biophysical Research Communications, 1995
- Cloning of Rat and Mouse P2Y PurinoceptorsBiochemical and Biophysical Research Communications, 1995
- How should P2x purinoceptors be classified pharmacologically?Trends in Pharmacological Sciences, 1995
- G protein-coupled P2 purinoceptors: from molecular biology to functional responsesTrends in Pharmacological Sciences, 1995
- Site-directed Mutagenesis of P2U Purinoceptors: POSITIVELY CHARGED AMINO ACIDS IN TRANSMEMBRANE HELICES 6 AND 7 AFFECT AGONIST POTENCY AND SPECIFICITYPublished by Elsevier ,1995
- Cloning and functional expression of a brain G‐protein‐coupled ATP receptorFEBS Letters, 1993
- The effects of some possible inhibitors of ectonucleotidases on the breakdown and pharmacological effects of ATP in the guinea-pig urinary bladderGeneral Pharmacology: The Vascular System, 1989